Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays

Glioblastoma is the most common and deadly primary brain malignancy. Despite advances in precision medicine oncology (PMO) allowing the identification of molecular vulnerabilities in glioblastoma, treatment options remain limited, and molecular assays guided by genomic and expression profiling to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadwick, Michelle, Yang, Chen, Liu, Liqiong, Gamboa, Christian Moya, Jara, Kelly, Lee, Howon, Sabaawy, Hatem E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393526/
https://www.ncbi.nlm.nih.gov/pubmed/32731171
http://dx.doi.org/10.1016/j.isci.2020.101365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393526/
https://www.ncbi.nlm.nih.gov/pubmed/32731171
http://dx.doi.org/10.1016/j.isci.2020.101365

Ejemplares similares